Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

NCT04341142 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2024-05-22

No results posted yet for this study

Summary

Covid-SER is a prospective multi-center study for the evaluation of diagnostic performance of available serological tests

Conditions

  • CoV2 Positive Caregivers

Interventions

DIAGNOSTIC_TEST

Serological tests will be applied on patients blood sampling

Application of tests on patients' serum

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-10
Primary Completion
2023-04-10
Completion
2026-10-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04341142 on ClinicalTrials.gov